Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Chinese Patent Office
Deloitte
Fish and Richardson
Cipla
McKinsey
Citi
Merck
Baxter

Generated: November 17, 2018

DrugPatentWatch Database Preview

TESTOSTERONE ENANTHATE Drug Profile

« Back to Dashboard

Which patents cover Testosterone Enanthate, and what generic alternatives are available?

Testosterone Enanthate is a drug marketed by Hikma Farmaceutica, Mylan Institutional, Nexus Pharms, Watson Labs, and Watson Pharms Inc. and is included in eight NDAs.

The generic ingredient in TESTOSTERONE ENANTHATE is estradiol valerate; testosterone enanthate. There are seventy-five drug master file entries for this compound. Additional details are available on the estradiol valerate; testosterone enanthate profile page.

Drug patent expirations by year for TESTOSTERONE ENANTHATE
Pharmacology for TESTOSTERONE ENANTHATE
Ingredient-typeAndrostanes
Drug ClassAndrogen
Mechanism of ActionAndrogen Receptor Agonists

US Patents and Regulatory Information for TESTOSTERONE ENANTHATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hikma Farmaceutica TESTOSTERONE ENANTHATE testosterone enanthate INJECTABLE;INJECTION 091120-001 Sep 18, 2012 AO RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Watson Pharms Inc TESTOSTERONE ENANTHATE testosterone enanthate INJECTABLE;INJECTION 085598-001 Approved Prior to Jan 1, 1982 AO RX No Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Watson Labs TESTOSTERONE ENANTHATE testosterone enanthate INJECTABLE;INJECTION 083667-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Watson Labs TESTOSTERONE ENANTHATE AND ESTRADIOL VALERATE estradiol valerate; testosterone enanthate INJECTABLE;INJECTION 085865-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Mylan Institutional TESTOSTERONE ENANTHATE testosterone enanthate INJECTABLE;INJECTION 040647-001 Oct 5, 2009 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Nexus Pharms TESTOSTERONE ENANTHATE testosterone enanthate INJECTABLE;INJECTION 040575-001 Jun 14, 2006 AO RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Watson Labs TESTOSTERONE ENANTHATE testosterone enanthate INJECTABLE;INJECTION 083667-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Chinese Patent Office
Deloitte
Fish and Richardson
Cipla
McKinsey
Citi
Merck
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.